Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer
It is the second approved indication in India and expands use of the Shanghai Junshi Biosciences’ drug beyond the initially approved indication in nasopharyngeal carcinoma
· 10/21/2026, 7:03:14 AM· 2 min read
It is the second approved indication in India and expands use of the Shanghai Junshi Biosciences’ drug beyond the initially approved indication in nasopharyngeal carcinoma
Read original story →
